Aprotinin vs. tranexamic acid in isolated coronary artery bypass surgery A multicentre observational study

作者：Deloge Elsa; Amour Julien; Provenchere Sophie; Rozec Bertrand; Scherrer Bruno; Ouattara Alexandre^*

来源：European Journal of Anaesthesiology, 2017, 34(5): 280-287.

DOI：10.1097/EJA.0000000000000604

BACKGROUND Aprotinin appears to be more efficacious than lysine analogues to reduce bleeding and transfusion of blood products in high-transfusion-risk cardiac surgical patients. However, in isolated coronary artery bypass graft (CABG) surgery, the results from head-to-head trials remain less conclusive.
OBJECTIVE Our objective was to compare the efficacies and safety of aprotinin and tranexamic acid (TXA) in patients undergoing isolated on-pump CABG.
DESIGN A multicentre before-and-after study pooling individual data from published trials and unpublished data from three other databases.
SETTING Four tertiary care teaching hospitals (HautLeveque Hospital in Bordeaux, Pitie-Salpetriere Hospital and Bichat-Claude Bernard Hospital in Paris, and Laennec Hospital in Nantes). PATIENTS We included data of 2496 isolated on-pump CABGsurgery patientswhoreceived either aprotinin between November 2003 and May 2008 (n = 1267) or TXA between November 2007 and November 2013 (n = 1229).
MAIN OUTCOME MEASURES The primary outcome was total blood loss within 24 h after operation. Secondary outcomes were transfusion of blood products, reoperation for bleeding, renal replacement therapy, ICU length of stay and in-hospital mortality.
RESULTS Adjusted mean (SEM) 24-h blood loss after surgery [483 (11) vs. 634 (11) ml, P< 0.0001] and the proportion of patients requiring intraoperative blood product transfusion (32.7 vs. 46.5%, P = 0.01) were lower in aprotinin - treated patients. No difference was observed with regard to reoperations for bleeding, renal replacement therapy and in-hospital mortality. However, patients receiving aprotinin had a significantly shorter adjusted ICU length of stay.
CONCLUSION In patients undergoing isolated CABG, aprotinin was more effective than TXA in reducing postoperative blood loss, and no safety concerns were identified. The benefits of aprotinin should be considered when evaluating the risk of major blood loss and transfusion in patients scheduled for isolated CABG surgery.

• 出版日期2017-5
• 单位河南工业大学